at a time the world is crying out for Telehealth solutions RAP has had a rather important door slammed shut...fact is the products are not robust enough to justify approval....can't see sanofi being to excited either
Ann: Update on US FDA De Novo Classification Request, page-44
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
